Test bank
l
, TestBankForUnderstanding Pharmacology,Essentials for
l l l l l l
Medication Safety, 3rd Edition,Workman & LaCharity
l l l l l l
Chapter 01: Drug Regulation, Actions, and Responses
l l l l l l
MULTIPLE lCHOICE
l BASIC lCONCEPTS
1. Which lhealth lcare lprofessional lhas lthe lmajor lresponsibility lfor ldispensing lprescribed
ldrugs lunder lthe ldirection lof la lpharmacist?
a. Physician
b Nurse lpractitioner
.
c. Licensed lnurse
d Pharmacy ltechnician
.
ANS: l D
The lphysician land lnurse lpractitioner lhave lthe lmajor lresponsibility lfor lprescribing ldrugs, lnot
ldispensing lthem. lThe llicensed lnurse lhas lthe lprimary lresponsibility lfor ladministering ldrugs,
lalthough lunder lsome lcircumstances la llicensed lnurse lmay ldispense lprescribed ldrugs lbut lthis lis
lnot lhis lor lher lmajor lresponsibility lin ldrug ltherapy. lThe lpharmacy ltechnician lhas lthe lmajor
lresponsibility lof ldispensing lprescribed ldrugs lunder lthe ldirection lof la llicensed lpharmacist.
DIF: Cognitive lLevel: lRemembering REF: p. l3
2. Which lterm ldescribes lthe leffect lof la ldrug lthat limproves lbody lfunction?
a. Side leffect
b Intended laction
.
c. Adverse lreaction
d Idiosyncratic lresponse
.
ANS: l B
The lpurpose lof ldrug ltherapy lis lto ltake la ldrug lto lprevent, lreduce, lor lcorrect la lhealth lproblem.
lThis lresponse lis lany ldrug’s lintended laction lalso lknown las la ltherapeutic lresponse.
DIF: Cognitive lLevel: lRemembering REF: p. l3
3. Which ltype lof ldrug lname lis l“owned” lby lthe lcompany lthat lmanufactures lit?
a. Generic lname
b Chemical lname
, .
c. Category lname
d Trade lname
.
ANS: l D
The lchemical lname lis la ldrug’s lexact lchemical lcomposition. lThe lgeneric lname lis lthe lname
lassigned lto lthe ldrug lby lthe lU.S. lAdopted lNames lCouncil land lis lnot lowned lby lanyone. lThe
lcategory lname lrefers lto lthe ltype lof ldrug l(what lit ldoes lor lwhat lit lis lused lfor) land lis lnot lan lactual
ldrug lname. lThe ltrade lname l(brand lname) lis lthe lname lprovided land lowned lby la lspecific ldrug’s
lmanufacturer.
DIF: Cognitive lLevel: lRemembering REF: p. l4
4. Which ldrug lor ldrug lclass lis la l“high lalert” ldrug?
a. Penicillin
b Insulin
.
c. NSAIDs
d Calcium
.
ANS: l B
A lhigh lalert ldrug lis lone lin lwhich lharm lis llikely lto lresult lif lgiven lat lthe lwrong ldose, lto lthe
lwrong lpatient, lor lnot lgiven lto lthe lcorrect lpatient. lDrugs lclassified las lhigh lalert ldrugs linclude
lpotassium, lnarcotics l(opioids), linsulin, lcancer lchemotherapy ldrugs, land lheparin l(or lany ldrug
lthat lstrongly laffects lblood lclotting). lPenicillin, lNSAIDs, land lcalcium lare lnot lconsidered lhigh
lalert ldrugs.
DIF: Cognitive lLevel: lRemembering REF: p. l4
5. What lis lthe lterm lfor la ldrug lthat lhas lthe lsame laction las la lnaturally loccurring
lbody lhormone lor lenzyme?
a. Agonist
b Blocking lagent
.
c. Chemical
d Duplicator
.
ANS: l A
A ldrug lagonist lis lan lextrinsic ldrug lthat lactivates lthe lreceptor lsites lof la lcell land lmimics lthe
lactions lof lnaturally lo ccurring lbody lsubstances l (intrinsic ldrugs). lA lblocking lagent lis la ldrug
, antagonist. lA lchemical lwould lnot lnecessarily lbe la ldrug lat lall. lA lduplicator lis lnot la lpharmacologic
lterm.
DIF: Cognitive lLevel: lRemembering REF: pp. l6-7
6. Which lterm ldescribes lhow lthe lbody laffects ldrug lactivity?
a. Drug lpotency
b Pharmacodynamics
.
c. Therapeutic leffect
d Pharmacokinetics
.
ANS: l D
The lterm lpharmacokinetics lrefers lto ldrug lmetabolism land lhow lthe lbody lchanges la ldrug.
lPharmacodynamics lrefers lto lhow la ldrug lworks lto lchange lbody lfunction. lDrug lpotency lrefers lto
lhow lstrongly lor lto lwhat ldegree la ldrug lexerts lits l effects. lThe ltherapeutic leffect lis lcloser lto
lpharmacodynamics, lmeaning lhow la ldrug lworks lto lchange lbody lfunction.
DIF: Cognitive lLevel: lRemembering REF: p. l10
7. In lthe lUnited lStates, lwhich lgroup lis lresponsible lfor lenforcing lestablished lstandards lfor
ldrug lmanufacturing?
a. U.S. lPharmacopeia
b National lInstitutes lof lHealth
.
c. Food land lDrug lAdministration
d Association lof lPharmaceutical lManufacturers
.
ANS: l C
The lstandards lfor ldrug lmanufacture lare lestablished lby lthe lU.S. lPharmacopeia. lThese
lstandards lare lenforced lby lthe lFood land lDrug lAdministration. lNeither lthe lNational lInstitutes
lof lHealth lnor lthe lAssociation lof lPharmaceutical lManufacturers lhas lany lauthority lto lenforce
ldrug lstandards.
DIF: l l Cognitive lLevel: lRemembering l l l REF: l l p. l5
8. Which lfactor lis la lmajor ldisadvantage lof lthe ltransdermal ldrug ldelivery lroute?
a. Only la lprescriber lcan ladminister ldrugs lby lthe ltransdermal lroute.
b Transdermal ldrugs lmust lbe lsterile lrather lthan lclean.
.
c. First lpass ldrug lloss lby lthis lroute lis lthe lmost lextensive.
d Drug labsorption lis ldependent lon ladequate lcirculation.
l
, TestBankForUnderstanding Pharmacology,Essentials for
l l l l l l
Medication Safety, 3rd Edition,Workman & LaCharity
l l l l l l
Chapter 01: Drug Regulation, Actions, and Responses
l l l l l l
MULTIPLE lCHOICE
l BASIC lCONCEPTS
1. Which lhealth lcare lprofessional lhas lthe lmajor lresponsibility lfor ldispensing lprescribed
ldrugs lunder lthe ldirection lof la lpharmacist?
a. Physician
b Nurse lpractitioner
.
c. Licensed lnurse
d Pharmacy ltechnician
.
ANS: l D
The lphysician land lnurse lpractitioner lhave lthe lmajor lresponsibility lfor lprescribing ldrugs, lnot
ldispensing lthem. lThe llicensed lnurse lhas lthe lprimary lresponsibility lfor ladministering ldrugs,
lalthough lunder lsome lcircumstances la llicensed lnurse lmay ldispense lprescribed ldrugs lbut lthis lis
lnot lhis lor lher lmajor lresponsibility lin ldrug ltherapy. lThe lpharmacy ltechnician lhas lthe lmajor
lresponsibility lof ldispensing lprescribed ldrugs lunder lthe ldirection lof la llicensed lpharmacist.
DIF: Cognitive lLevel: lRemembering REF: p. l3
2. Which lterm ldescribes lthe leffect lof la ldrug lthat limproves lbody lfunction?
a. Side leffect
b Intended laction
.
c. Adverse lreaction
d Idiosyncratic lresponse
.
ANS: l B
The lpurpose lof ldrug ltherapy lis lto ltake la ldrug lto lprevent, lreduce, lor lcorrect la lhealth lproblem.
lThis lresponse lis lany ldrug’s lintended laction lalso lknown las la ltherapeutic lresponse.
DIF: Cognitive lLevel: lRemembering REF: p. l3
3. Which ltype lof ldrug lname lis l“owned” lby lthe lcompany lthat lmanufactures lit?
a. Generic lname
b Chemical lname
, .
c. Category lname
d Trade lname
.
ANS: l D
The lchemical lname lis la ldrug’s lexact lchemical lcomposition. lThe lgeneric lname lis lthe lname
lassigned lto lthe ldrug lby lthe lU.S. lAdopted lNames lCouncil land lis lnot lowned lby lanyone. lThe
lcategory lname lrefers lto lthe ltype lof ldrug l(what lit ldoes lor lwhat lit lis lused lfor) land lis lnot lan lactual
ldrug lname. lThe ltrade lname l(brand lname) lis lthe lname lprovided land lowned lby la lspecific ldrug’s
lmanufacturer.
DIF: Cognitive lLevel: lRemembering REF: p. l4
4. Which ldrug lor ldrug lclass lis la l“high lalert” ldrug?
a. Penicillin
b Insulin
.
c. NSAIDs
d Calcium
.
ANS: l B
A lhigh lalert ldrug lis lone lin lwhich lharm lis llikely lto lresult lif lgiven lat lthe lwrong ldose, lto lthe
lwrong lpatient, lor lnot lgiven lto lthe lcorrect lpatient. lDrugs lclassified las lhigh lalert ldrugs linclude
lpotassium, lnarcotics l(opioids), linsulin, lcancer lchemotherapy ldrugs, land lheparin l(or lany ldrug
lthat lstrongly laffects lblood lclotting). lPenicillin, lNSAIDs, land lcalcium lare lnot lconsidered lhigh
lalert ldrugs.
DIF: Cognitive lLevel: lRemembering REF: p. l4
5. What lis lthe lterm lfor la ldrug lthat lhas lthe lsame laction las la lnaturally loccurring
lbody lhormone lor lenzyme?
a. Agonist
b Blocking lagent
.
c. Chemical
d Duplicator
.
ANS: l A
A ldrug lagonist lis lan lextrinsic ldrug lthat lactivates lthe lreceptor lsites lof la lcell land lmimics lthe
lactions lof lnaturally lo ccurring lbody lsubstances l (intrinsic ldrugs). lA lblocking lagent lis la ldrug
, antagonist. lA lchemical lwould lnot lnecessarily lbe la ldrug lat lall. lA lduplicator lis lnot la lpharmacologic
lterm.
DIF: Cognitive lLevel: lRemembering REF: pp. l6-7
6. Which lterm ldescribes lhow lthe lbody laffects ldrug lactivity?
a. Drug lpotency
b Pharmacodynamics
.
c. Therapeutic leffect
d Pharmacokinetics
.
ANS: l D
The lterm lpharmacokinetics lrefers lto ldrug lmetabolism land lhow lthe lbody lchanges la ldrug.
lPharmacodynamics lrefers lto lhow la ldrug lworks lto lchange lbody lfunction. lDrug lpotency lrefers lto
lhow lstrongly lor lto lwhat ldegree la ldrug lexerts lits l effects. lThe ltherapeutic leffect lis lcloser lto
lpharmacodynamics, lmeaning lhow la ldrug lworks lto lchange lbody lfunction.
DIF: Cognitive lLevel: lRemembering REF: p. l10
7. In lthe lUnited lStates, lwhich lgroup lis lresponsible lfor lenforcing lestablished lstandards lfor
ldrug lmanufacturing?
a. U.S. lPharmacopeia
b National lInstitutes lof lHealth
.
c. Food land lDrug lAdministration
d Association lof lPharmaceutical lManufacturers
.
ANS: l C
The lstandards lfor ldrug lmanufacture lare lestablished lby lthe lU.S. lPharmacopeia. lThese
lstandards lare lenforced lby lthe lFood land lDrug lAdministration. lNeither lthe lNational lInstitutes
lof lHealth lnor lthe lAssociation lof lPharmaceutical lManufacturers lhas lany lauthority lto lenforce
ldrug lstandards.
DIF: l l Cognitive lLevel: lRemembering l l l REF: l l p. l5
8. Which lfactor lis la lmajor ldisadvantage lof lthe ltransdermal ldrug ldelivery lroute?
a. Only la lprescriber lcan ladminister ldrugs lby lthe ltransdermal lroute.
b Transdermal ldrugs lmust lbe lsterile lrather lthan lclean.
.
c. First lpass ldrug lloss lby lthis lroute lis lthe lmost lextensive.
d Drug labsorption lis ldependent lon ladequate lcirculation.
